National Health Investors (NHI) 10-Q2024 Q1 Quarterly report

Filed: 6 May 24, 4:06pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: ASU, Bloomington, buyer, Carriage, CODM, confidential, count, Crossing, cybersecurity, deferral, disruptive, expended, explanation, firm, franchise, Identification, improving, incident, investee, Louisiana, notification, registered, regulation, reset, scope, Senor, standard, Topic, TTM, Wisconsin

Removed: accounted, accrue, achievement, actively, added, affirmed, anticipate, assigned, award, bearing, borrow, broad, closed, closing, collectible, combination, commenced, conform, constructively, coupled, curb, Department, deployment, designation, determine, developed, difficult, disposal, driven, effort, enforcement, escrow, escrowed, eventual, favorable, FDIC, Formation, Frederick, globally, high, hold, inability, increasing, initiated, Innovation, interference, international, legacy, legal, longer, lower, macroeconomic, marketed, multiple, Nevada, organizational, periodically, PPP, predetermined, prepaid, range, recently, recession, reclassified, released, replacing, reputational, restructured, Retained, retired, return, revised, separated, Silicon, Silverado, single, sufficiently, Summerlin, systemic, tighter, transferred, treasury, unable, unauthorized, uninsured, Valley, Welltower

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated NHI transcripts

NHI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002, that, to the undersigned's best knowledge and belief, the quarterly report on Form 10-Q for National Health Investors, Inc. ("Issuer") for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"):

(a)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.


Date:	May 6, 2024	/s/ D. Eric Mendelsohn
		D. Eric Mendelsohn
		President, Chief Executive Officer and Director
		(Principal Executive Officer)



Date:	May 6, 2024	/s/ John L. Spaid
		John L. Spaid
		Chief Financial Officer
		(Principal Financial Officer)